Literature DB >> 16895815

Interrater reliability of measurements of comorbid illness should be reported.

Stephen F Hall1, Patti A Groome, David L Streiner, Paula A Rochon.   

Abstract

OBJECTIVE: Comorbidity indices are commonly used to stratify patients to control for treatment selection bias. The objectives here were to review the reporting of interrater reliability when studies use comorbidity indices in clinical research publications and to report the interrater reliability of four common indices in a particular research setting. STUDY DESIGN AND
SETTING: Four trained abstractors reviewed the same 40 charts of patients with squamous cell carcinoma of the head and neck from a regional cancer center. Scores for the Charlson Index, the Index of Co-existent Disease, the Cumulative Illness Rating Scale, and the Kaplan-Feinstein Classification were calculated, and the intraclass correlation coefficient was used to assess interrater reliability.
RESULTS: The details on the training of abstractors and the results of interrater reliability tests are not commonly reported. In our study setting, the Charlson Index had excellent reliability and the others had acceptable reliability.
CONCLUSION: If the quality of a study using an index or scale is to be assessed, the reliability and interrater reliability of the score assignment process should be reported.

Entities:  

Mesh:

Year:  2006        PMID: 16895815     DOI: 10.1016/j.jclinepi.2006.02.006

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  14 in total

1.  Validation of the Charlson comorbidity index in patients undergoing revision total hip arthroplasty.

Authors:  Jan Schmolders; Max J Friedrich; Robert Michel; Andreas C Strauss; Matthias D Wimmer; Thomas M Randau; Peter H Pennekamp; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2015-06-24       Impact factor: 3.075

2.  How I assess comorbidities before hematopoietic cell transplantation.

Authors:  Mohamed L Sorror
Journal:  Blood       Date:  2013-01-25       Impact factor: 22.113

3.  Comorbidity scores reported in anatomic and reverse total shoulder arthroplasty: a systematic review.

Authors:  Joshua D Meade; Garrett R Jackson; Michael S Schallmo; Bradley Young; Robert L Parisien; David P Trofa; Patrick M Connor; Shadley Schiffern; Nady Hamid; Bryan M Saltzman
Journal:  Int Orthop       Date:  2022-06-06       Impact factor: 3.479

4.  Perceived Control Predicts Symptom Status in Patients With Heart Failure.

Authors:  Chin-Yen Lin; Jennifer L Miller; Terry A Lennie; Martha J Biddle; Gia Mudd-Martin; Muna Hammash; Debra K Moser
Journal:  J Cardiovasc Nurs       Date:  2020 Nov/Dec       Impact factor: 2.083

5.  Outdoor life in dementia: How predictable are people with dementia in their mobility?

Authors:  Sayeh Bayat; Alex Mihailidis
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-13

6.  Association of Hypertension with Knee Pain Severity Among People with Knee Osteoarthritis.

Authors:  Xiaojun Shi; Elizabeth A Schlenk
Journal:  Pain Manag Nurs       Date:  2021-08-31       Impact factor: 1.929

Review 7.  Evaluating comorbidities in total hip and knee arthroplasty: available instruments.

Authors:  Kristian Bjorgul; Wendy M Novicoff; Khaled J Saleh
Journal:  J Orthop Traumatol       Date:  2010-11-13

8.  Factors associated with life-sustaining treatment restriction in a general intensive care unit.

Authors:  Stein Arve Skjaker; Henrik Hoel; Vegard Dahl; Knut Stavem
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

9.  Charlson comorbidity index derived from chart review or administrative data: agreement and prediction of mortality in intensive care patients.

Authors:  Knut Stavem; Henrik Hoel; Stein Arve Skjaker; Rolf Haagensen
Journal:  Clin Epidemiol       Date:  2017-06-02       Impact factor: 4.790

10.  "Concordance between comorbidity data from patient self-report interviews and medical record documentation".

Authors:  William Corser; Alla Sikorskii; Ade Olomu; Manfred Stommel; Camille Proden; Margaret Holmes-Rovner
Journal:  BMC Health Serv Res       Date:  2008-04-16       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.